Evidence for SMOF Lipid in Pediatric ARDS

Current Management Strategies for Pediatric ARDS

The American Thoracic Society suggests a trial of non-invasive mechanical ventilation over invasive mechanical ventilation in children with sepsis-induced PARDS who don't have clear indications for intubation and are responding to initial resuscitation 1, 2
High positive end-expiratory pressure (PEEP) is recommended in children with sepsis-induced PARDS, though the exact level has not been determined 1, 3
Lung-protective ventilation with low tidal volumes (4-8 ml/kg predicted body weight) and limited plateau pressures is the cornerstone of PARDS management, as recommended by the Society of Critical Care Medicine 4

A trial of prone positioning is suggested in children with sepsis and severe PARDS for at least 12 hours per day, as tolerated, according to the European Society of Intensive Care Medicine 1, 2, 3
Neuromuscular blockade is suggested in children with sepsis and severe PARDS, typically for 24-48 hours after ARDS onset, as recommended by the European Society of Intensive Care Medicine 1, 3
Inhaled nitric oxide (iNO) is not recommended for routine use in all children with sepsis-induced PARDS, as stated by the American Thoracic Society 1, 2
iNO may be used as a rescue therapy in children with sepsis-induced PARDS and refractory hypoxemia after other oxygenation strategies have been optimized, according to the European Society of Intensive Care Medicine 1, 3

Avoiding excessive fluid administration is important to prevent worsening pulmonary edema in pediatric patients with PARDS, as recommended by the Society of Critical Care Medicine 4
Conservative fluid management should be implemented once respiratory status is stable, according to the Society of Critical Care Medicine 5

Current pediatric ARDS guidelines do not specifically address the use of SMOF lipid emulsions, as noted by the European Society of Intensive Care Medicine 1, 2, 3
The Surviving Sepsis Campaign guidelines for pediatric septic shock and sepsis-associated organ dysfunction do not provide specific recommendations regarding lipid emulsion types for PARDS, as stated by the Society of Critical Care Medicine 1, 2, 3

Treatment should focus on established strategies including appropriate ventilation techniques, prone positioning when indicated, and judicious use of adjunctive therapies, as recommended by the Society of Critical Care Medicine 4, 5

Clinicians should follow established guidelines for pediatric ARDS management while awaiting more specific evidence regarding optimal lipid emulsion composition, as recommended by the European Society of Intensive Care Medicine and the Society of Critical Care Medicine 1, 4